Novel Quality Control Metric for the Pharmacotherapy of Major Depressive Disorder: Measuring Guideline Concordance and Its Impact on Symptom Severity

Conclusions: By measuring naturalistic MDD pharmacotherapy guideline concordance with the GCA-8, we revealed potential treatment gaps and an inverse association between guideline concordance and MDD symptom severity.PMID:38175947 | DOI:10.4088/JCP.23m14916

Source: Journal of Clinical Psychiatry - January 4, 2024 Category: Psychiatry Authors: Mason T Breitzig Fan He Lan Kong Guodong Liu Daniel A Waschbusch Jeff D Yanosky Erika F H Duanping Liao Source Type: research